[{"NetIncomeLoss_1_Q3_USD":-30155.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":218646030.0,"AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent_0_Q3_USD":35025.0,"IncreaseDecreaseInPrepaidExpensesOther_1_Q3_USD":302955.0,"AssetsCurrent_0_Q3_USD":1741579.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":25000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q3_USD":-230000000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":16667.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GeneralAndAdministrativeExpense_1_Q3_USD":36307.0,"RepaymentsOfRelatedPartyDebt_1_Q3_USD":250000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"Liabilities_0_Q3_USD":8101692.0,"Cash_0_Q3_USD":1438624.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":302955.0,"PaymentsOfStockIssuanceCosts_1_Q3_USD":659781.0,"NetCashProvidedByUsedInFinancingActivities_1_Q3_USD":231761219.0,"ProceedsFromIssuanceOfPrivatePlacement_1_Q3_USD":6600000.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":230006152.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"ProceedsFromRelatedPartyDebt_1_Q3_USD":250000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"Assets_0_Q3_USD":231747731.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q3_USD":218646030.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":0.0,"AdditionalPaidInCapital_0_Q3_USD":5029475.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1438624.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q3_USD":1438624.0,"LiabilitiesCurrent_0_Q3_USD":51692.0,"NetCashProvidedByUsedInOperatingActivities_1_Q3_USD":-322595.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-30155.0,"DeferredTaxAssetsGross_0_Q3_USD":7600.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-30155.0,"StockholdersEquity_0_Q3_USD":5000009.0,"DeferredOfferingCosts_0_Q3_USD":12948806.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":7600.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":231747731.0,"PreferredStockValue_0_Q3_USD":0.0,"InvestmentIncomeInterest_1_Q3_USD":6152.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q3_USD":225796000.0,"OperatingIncomeLoss_1_Q3_USD":-36307.0,"ProceedsFromIssuanceOfCommonStock_1_Q3_USD":25000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_1_Q3_USD":16667.0,"Ticker":"OWLT","CIK":"1816708","name":"SANDBRIDGE ACQUISITION CORP","OfficialName":"Owlet Inc. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"494104905.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20201113"}]